Guillaume Becker

In vivo imaging of synaptic loss in Alzheimer’s disease with [18F]UCB-H positron emission tomography

Christine Bastin, Mohamed Ali Bahri, François Meyer et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2019 · 124 citations · Full text

Medicine, Neurobiology, Neuroscience +16

Syntheses, Radiolabelings, and in Vitro Evaluations of Fluorinated PET Radioligands of 5-HT₆Serotoninergic Receptors

Julie Colomb, Guillaume Becker, Sylvain Fieux et al. · Journal of Medicinal Chemistry · 2014 · 59 citations · Full text

Medicine, Nuclear Medicine, Pharmacology +17

Measuring brain synaptic vesicle protein 2A with positron emission tomography and [ ¹⁸ F]UCB‐H

Mohamed Ali Bahri, Alain Plenevaux, Joël Aerts et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2017 · 58 citations · Full text

Medicine, Neurobiology, Neuroscience +17

Enabling Efficient Positron Emission Tomography (PET) Imaging of Synaptic Vesicle Glycoprotein 2A (SV2A) with a Robust and One-Step Radiosynthesis of a Highly Potent ¹⁸F-Labeled Ligand ([¹⁸F]UCB-H)

Corentin Warnier, Christian Lemaire, Guillaume Becker et al. · Journal of Medicinal Chemistry · 2016 · 57 citations

Medicine, Medicinal Chemistry, Nuclear Medicine +17

Selective serotonin 5-HT1A receptor biased agonists elicitdistinct brain activation patterns: a pharmacoMRI study

Guillaume Becker, Radu Bolbos, Nicolas Costes et al. · Scientific Reports · 2016 · 54 citations · Full text

Medicine, Neuroscience, Pharmacology +15